Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Malawi has experienced significant growth in recent years, driven by various factors such as increasing awareness of the importance of vaccination and rising healthcare expenditure.
Customer preferences: Malawian customers have shown a growing interest in preventative healthcare, resulting in an increased demand for vaccines. This trend is particularly evident in the Other Vaccines market, which includes vaccines for diseases other than the common childhood illnesses. Customers are increasingly seeking protection against diseases such as yellow fever, meningitis, and rabies, which are prevalent in Malawi.
Trends in the market: The Other Vaccines market in Malawi has seen a surge in demand for vaccines against diseases such as yellow fever and meningitis due to recent outbreaks in the country. In addition, the government's efforts to increase vaccination coverage and improve access to healthcare services have also contributed to the growth of the market. The market has also witnessed the introduction of new vaccines, such as the HPV vaccine, which has been made available to adolescent girls in Malawi to prevent cervical cancer.
Local special circumstances: Malawi has a high burden of infectious diseases, making vaccination a crucial aspect of public health. The country has experienced several outbreaks of vaccine-preventable diseases in recent years, which have highlighted the need for increased vaccination coverage. Malawi also has a high prevalence of HIV/AIDS, which has weakened the immune systems of many individuals, making them more susceptible to infectious diseases. As a result, the government has prioritized vaccination programs to protect vulnerable populations.
Underlying macroeconomic factors: The growth of the Other Vaccines market in Malawi is also influenced by macroeconomic factors such as rising healthcare expenditure and increasing government funding for healthcare. The government has made significant investments in the healthcare sector, including the expansion of healthcare facilities and the recruitment of healthcare workers. This has led to increased access to healthcare services and a greater demand for vaccines. Additionally, Malawi has received support from international organizations such as GAVI, which has provided funding for vaccination programs in the country. In conclusion, the Other Vaccines market in Malawi has experienced significant growth due to increasing customer demand for preventative healthcare, the government's efforts to improve vaccination coverage, and the country's high burden of infectious diseases. The market is expected to continue growing in the coming years, driven by rising healthcare expenditure and increased government funding for healthcare.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
